163,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in über 4 Wochen
  • Broschiertes Buch

The book provides a broad view of proteomics in both basic and clinical cancer research, offering practical tools through discussion of methodology and procedures, as well as presentation of step-by-step protocols. It emphasizes the application of emerging technology to a broad range of research and therapeutic problems in cancer. It covers basic principles along with a detailed presentation of new and emerging applications.

Produktbeschreibung
The book provides a broad view of proteomics in both basic and clinical cancer research, offering practical tools through discussion of methodology and procedures, as well as presentation of step-by-step protocols. It emphasizes the application of emerging technology to a broad range of research and therapeutic problems in cancer. It covers basic principles along with a detailed presentation of new and emerging applications.
Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Autorenporträt
Dr. Daniel C. Liebler is Professor, Department of Pharmacology and Toxicology, and Director, Southwest Environmental Health Sciences Center at the University of Arizona College of Pharmacy. He is also Director of the Toxicology Training Program and a member of the Arizona Cancer Center, as well as the author of Introduction to Proteomics (2001).